Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers
Nabamita Boruah, David Hoyos, Renyta Moses, Ryan M. Hausler, Heena Desai, A Dinh Le, Madeline Good, Gregory Kelly, Ashvathi Raghavakaimal, Maliha N Tayeb, Mohana Narasimhamurthy, Abigail G. Doucette, Peter Edward Gabriel, Michael D. Feldman, Jinae Park, , Kara N. Maxwell
This study compares genomic and immunologic features of germline TP53-driven breast cancers to sporadic breast cancers, finding distinct patterns of genomic instability and immune infiltration.
Nature Communications · May 21, 2026Peer-reviewedGenetics